Schedule 13G ownership disclosure

REATA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75615P103

Event date: 2023-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,730,841
Percent of class
5.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-003736
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Jun 26, 2023
Reporting period
Jun 16, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub